Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-08 Purchase |
2022-06-10 6:24 pm |
Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Commercial Officer |
28,200 | $0.71 | $20,022 | 36,200 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Option Award |
2025-02-07 4:22 pm |
N/A 2035-02-04 |
Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick CHIEF OPERATING OFFICER |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-22 5:19 pm |
N/A 2034-05-19 |
Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick Chief Operating Officer |
188,000 | $0 | 188,000 (Direct) |
View |
Ownership |
2024-05-22 5:17 pm |
N/A 2034-02-28 |
Alto Neuroscience Inc. | ANRO | Hanley Jr. Michael Conick Chief Operating Officer |
0 | $0 | 8,000 (Direct) |
View |
| 2023-02-23 Option Award |
2023-02-24 6:22 pm |
N/A 2033-02-22 |
Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Business Officer |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-08-23 Option Award |
2022-08-25 7:35 pm |
N/A 2032-08-22 |
Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Business Officer |
130,000 | $0 | 130,000 (Direct) |
View |
| 2022-02-17 Option Award |
2022-02-22 4:51 pm |
N/A 2032-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Commercial Officer |
160,000 | $0 | 160,000 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 5:07 pm |
N/A 2031-02-16 |
Aeglea BioTherapeutics Inc. | AGLE | Hanley Jr. Michael Conick Chief Commercial Officer |
135,000 | $0 | 135,000 (Direct) |
View |